About Manon Oliero

Manon Oliero, Ph.D., specializes in nutrition and the gut microbiome, having completed her master's degree in microbiology with a focus on inflammatory bowel disease (IBD) and her Ph.D. on colorectal cancer. With a passion for improving public health, she is currently engaged in conducting clinical trials involving nutritional interventions. As a dedicated researcher, Manon emphasizes the importance of empowering individuals to take control of their health through knowledge sharing, contributing her expertise to Gut Microbiota For Health.

With the advancement of medicine, our population is undergoing a prolonged aging process. Over the next three decades, the global population aged over 65 years is set to more than double, reaching a staggering 1.5 billion individuals. The emergence of the gut microbiota as a potent modulator of healthy aging requires a concerted effort to allocate resources and research towards developing interventions aimed at promoting optimal gut health and longevity.

The low amount of bacteria from the gut microbiota able to process bilirubin, a product of heme degradation, during the neonatal period of life suggests a strong connection between the microbiome composition and development of jaundice in infants. In other words, the lack of certain bacteria in the gut of infants seems to be linked to the risk of developing jaundice.

Osteomicrobiology reveals a promising link between gut microbiota and osteoporosis prevention. New research highlights microbial strains influencing bone density, paving the way for targeted therapies. Further investigations will clarify this gut-bone axis and its potential in skeletal health.

Dietary fibers, known to regulate intestinal inflammation and gut barrier functions, have been avoided by patients with inflammatory bowel diseases (IBD) to avoid flare-ups. However, recent findings suggest that if fiber type, patient immunological condition, and the fermentative ability of the gut microbiota are taken into account, they could be beneficial and prevent relapses.

Restricting dietary fiber is a common advice for people living with inflammatory bowel disease. New research shows that not all fibers work the same and their impact on intestinal inflammation and gut barrier function depends on the type of fiber, individual immune status and the fermentative capacity of their gut microbes.

It’s time to delve into the world of short-chain fatty acids (SCFAs) and the crucial role they play in maintaining digestive health to gain a deeper understanding of how they contribute to overall well-being.

The gut microbiota is a hot topic. Research on the subject is constantly evolving and the goal is to create new gut microbiota-based therapies for preventing or curing disease, allowing patients to live healthy lives. At the 10th anniversary of the GMFH Summit, a panel of experts came together to share the latest in gut microbiota research. Now it’s our turn to share their insights with you.

Rural living, vaginal delivery, pet ownership, eating a wide variety of foods, low antibiotic use, and breast milk microbiota can prevent your children from developing a respiratory or food allergy. But what if differences in the gut microbiota could predict which children will grow out of their allergies?

Go to Top